Latest Funding News

James Hardie Industries plc reported a slight dip in FY25 sales and profits but met guidance, while announcing a transformative acquisition of The AZEK Company Inc to accelerate growth and synergies.

Macarthur Minerals has secured $250,000 through unsecured convertible notes to bolster its working capital and support ongoing operations amid challenging market conditions.

Yowie Group Ltd has firmly rejected the validity of director removal and nomination notices purportedly from Keybridge Capital, while confirming its status as Keybridge’s largest creditor with over $6.6 million owed. The company also detailed a recent share placement amid ongoing regulatory scrutiny.

HomeCo Daily Needs REIT has announced a quarterly distribution of 2.125 cents per unit for the period ending March 31, 2025, reaffirming its commitment to delivering steady income to investors.

360 Capital Mortgage REIT has secured a new $9.2 million senior loan and extended a $17.6 million facility, enhancing its portfolio diversification and maintaining its FY25 distribution guidance.

F.F.I. Holdings has corrected its earlier statement, confirming its $11 million entitlement offer at $3.50 per share is not underwritten. The offer aims to fund property development and debt reduction, with directors backing the raise.

Kingston Resources has agreed to sell its Misima Gold-Silver Project for $95 million, bolstering its balance sheet to accelerate growth at the Mineral Hill gold-copper operation. The transaction positions Kingston to expand production and exploration in the southern Cobar Basin.

Nanollose has successfully placed the $1.05 million shortfall from its recent entitlement offer, bolstering its capital to advance production and commercialisation of its innovative biomaterials.

Terrain Minerals has kicked off a 3,350-meter drilling campaign at its Lightning and Monza prospects, aiming to expand on recent high-grade gold and silver discoveries. Concurrently, the company has opened a $1.8 million rights issue to fund ongoing exploration and development.

Spacetalk Ltd reports robust 3QFY25 results, showcasing strong revenue growth and a sharp reduction in losses as it pivots to a subscription-driven family safety platform.

Elixinol Wellness Limited reported a robust FY24 performance, achieving an 81% increase in revenue and significantly narrowing its losses. The company is now focused on scaling its direct-to-consumer channels and operational efficiencies to reach profitability in 2025.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.